HighMark Wealth Management »

Trisalus Life Sciences shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Trisalus Life Sciences (TLSI) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Trisalus Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Trisalus Life Sciences held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trisalus Life Sciences by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $75k 11k 6.98

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Axogen (AXGN)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Us Vlu (IUSV)
Neogenomics Com New (NEO)
Wells Fargo & Company (WFC)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Anaptysbio Inc Common (ANAB)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
AtriCure (ATRC)
Si-bone (SIBN)

View all positions for HighMark Wealth Management

Top funds holding Trisalus Life Sciences

Nantahala Capital Management
Vanguard Group
AWM Investment Company
Gilder, Gagnon, Howe & Co
BlackRock
Geode Capital Management
Wealthcare Advisory Partners
Alyeska Investment Group
State Street Corporation
Northern Trust
Charles Schwab Investment Management
CWA Asset Management
Bridgeway Capital Management
Goldman Sachs Group
Bank of New York Mellon

View all funds holding Trisalus Life Sciences